The Role of Macular Pigment in Patients With Age-related Macular Degeneration
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00494325 |
Recruitment Status
:
Active, not recruiting
First Posted
: June 29, 2007
Last Update Posted
: April 11, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Age Related Maculopathy |
Study Type : | Observational |
Estimated Enrollment : | 500 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Role of Macular Pigment in Patients With Age-related Macular Degeneration |
Study Start Date : | October 2005 |
Actual Primary Completion Date : | December 2010 |
Estimated Study Completion Date : | December 2017 |

- Incidence of development of late AMD [ Time Frame: End of study ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- age related maculopathy
Exclusion Criteria:
- other macular diseases

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00494325
Switzerland | |
Klinik und Poliklinik für Augenheilkunde, University Bern | |
Bern, Switzerland |
Principal Investigator: | Sebastian Wolf, MD | University of Bern | |
Study Director: | Sebastian Wolf, MD PhD | University of Bern |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Sebastian Wolf, Director, University Hospital Inselspital, Berne |
ClinicalTrials.gov Identifier: | NCT00494325 History of Changes |
Other Study ID Numbers: |
KEK 73/05 SNF 3200 Bo-109962/1 ( Other Grant/Funding Number: SNF ) |
First Posted: | June 29, 2007 Key Record Dates |
Last Update Posted: | April 11, 2017 |
Last Verified: | April 2017 |
Keywords provided by Sebastian Wolf, University Hospital Inselspital, Berne:
age related maculopathy, macular pigment |
Additional relevant MeSH terms:
Macular Degeneration Retinal Degeneration Retinal Diseases Eye Diseases |